Ozonated olive oil ( DrugBank: Olive oil, Olive )
2 diseases
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
35 | 天疱瘡 | 1 |
162 | 類天疱瘡(後天性表皮水疱症を含む。) | 1 |
35. 天疱瘡
臨床試験数 : 99 / 薬物数 : 124 - (DrugBank : 36) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 169
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05594472 (ClinicalTrials.gov) | November 1, 2022 | 21/10/2022 | Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid | Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid Compared to Conventional Topical Treatment | Pemphigus Vulgaris;Bullous Pemphigoid | Drug: Ozonated olive oil;Drug: Topical garamycin cream | Cairo University | NULL | Recruiting | 18 Years | N/A | All | 30 | Phase 3 | Egypt |
162. 類天疱瘡(後天性表皮水疱症を含む。)
臨床試験数 : 90 / 薬物数 : 122 - (DrugBank : 47) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 144
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05594472 (ClinicalTrials.gov) | November 1, 2022 | 21/10/2022 | Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid | Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid Compared to Conventional Topical Treatment | Pemphigus Vulgaris;Bullous Pemphigoid | Drug: Ozonated olive oil;Drug: Topical garamycin cream | Cairo University | NULL | Recruiting | 18 Years | N/A | All | 30 | Phase 3 | Egypt |